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We compared behavioral risk factors and preventive measures
among female breast cancer survivors, female survivors of other
types of cancers, and women without a history of cancer. Surviv-
orship health care indicators for the 2 groups of cancer survivors
were compared.
Methods
Using data from the 2010 Behavioral Risk Factor Surveillance
System, we calculated the proportion of women with risk factors
and their engagement in preventive practices, stratified by cancer
status (cancer survivors or women with no history of cancer), and
compared the proportions after adjusting for sociodemographic
characteristics.
Results
A significantly higher proportion of breast cancer survivors had
mammography in the previous year (79.5%; 95% confidence inter-
val [CI], 76.0%–83.0%) than did other cancer survivors (68.1%;
95% CI,  65.6%–70.7%)  or  women  with  no  history  of  cancer
(66.4%; 95% CI, 65.5%–67.3%). Breast cancer survivors were
also more likely to have had a Papanicolaou (Pap) test within the
previous 3 years than women with no history of cancer (89.4%;
95% CI, 85.9%–93.0 vs 85.1%; 95% CI, 84.4%–85.8%) and a
colonoscopy  within  the  previous  10  years  (75.4%;  95%  CI,
71.7%–79.0%) than women with no history of  cancer (60.0%;
95% CI, 59.0%–61.0%). Current smoking was significantly lower
among survivors of breast cancer (10.3%; 95% CI, 7.4%–13.2%)
than other cancer survivors (20.8%; 95% CI, 18.4%–23.3%) and
women with no history of cancer (18.3%; 95% CI, 17.5%–19.1%).
After adjusting for sociodemographic characteristics, we found
that breast cancer survivors were significantly more likely to have
had mammography, a Pap test, and colonoscopy, and less likely to
be current smokers.
Conclusion
Breast cancer survivors are more likely to engage in cancer screen-
ing and less likely to be current smokers than female survivors of
other types of cancer or women with no history of cancer.
Introduction
In 2012, there were approximately 13.8 million cancer survivors in
the United States, of which 21.6% were female breast cancer sur-
vivors (1). Although the incidence of breast cancer among US wo-
men has been relatively stable during the past decade, deaths from
breast cancer have declined on average 1.9% each year from 2002
through 2011. Increased rates of breast cancer survivorship bring
with them potential health challenges (2), including recurrence, re-
lated  to  a  previous  breast  cancer  (3–5)  and  development  of  a
second primary cancer, a new cancer with a different histology
than a previous tumor (6–8).  In a large surveillance study, re-
searchers found that, on average, 12.3% of breast cancer survivors
had a second primary cancer, and this risk varied by age and can-
cer type with a mean time until the second cancer of 6.2 years (8
years for patients with breast cancer diagnosed prior to age 50 and
5.7 years for patients with breast cancer diagnosed at or older than
age 50)  (6).  Excess  risks  for  13 second primary cancers  were
found among breast cancer survivors. The leading sites of second
cancers on the basis of total cases (N = 44,249) were breast (n =
22,927; 51.8%), colorectal (n = 4,321; 9.8%), and lung (n = 3,507;
7.9%) cancers (6).
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Breast cancer recurrence and development of second primary can-
cers are affected by genetic (4,7,9) or hormonal factors (3), tumor
characteristics (10), treatments (3,4,7,8), and certain modifiable
risk factors (11,12) such as smoking, obesity, and alcohol con-
sumption. Engaging in physical activity may reduce the risk of
cancer recurrence and all-cause mortality (13,14). Providing pa-
tients with screening recommendations and guidance about health
promotion activities are part  of  high-quality survivorship care
(15). However, only limited information exists on the prevalence
of behavioral risk factors among breast cancer survivors. This in-
formation is crucial to planning for the best survivorship care for
optimal health results.
The purpose of this study was to compare the prevalence estim-
ates of behavioral risk factors and preventive practices, including
cancer screening, for female breast cancer survivors, female sur-
vivors of other types of cancer, and women with no history of can-
cer. We also examined survivorship health care to inform future
public  health  and  health  care  planning  and  care  management
strategies.
Methods
The Behavioral Risk Factor Surveillance System (BRFSS) is a
standardized, random-digit–dialed telephone survey of noninstitu-
tionalized US adults, implemented by health agencies in all 50
states, the District of Columbia, and 3 US territories. The primary
purpose of the BRFSS is to provide state-specific estimates of the
prevalence of self-reported behavioral risk factors associated with
the leading causes of death and disability in the United States. The
BRFSS questionnaire includes a set of core questions, optional
modules, and state-specific questions. Cancer screening questions
are included in the core questionnaire, and the 2010 BRFSS also
offered a cancer  survivorship optional  module.  The data were
weighted using post stratification methodology to adjust for the
unequal probability of selection, differential nonresponse, and pos-
sible deficiencies in the sampling frame (16,17).
The study population consisted of 39,235 women aged 18 years or
older who participated in the 2010 BRFSS in 1 of the 9 states and
1 territory that implemented the cancer survivorship optional mod-
ule. The women were stratified into 3 groups: 1) women with a
history of breast cancer (n = 1,310), 2) female survivors of a type
of cancer other than breast cancer (n = 3,556), and 3) women with
no history of cancer (n = 34,369). The study was limited to wo-
men with a single type of cancer.
Race and ethnicity were summarized in 4 categories: non-Hispan-
ic  white,  non-Hispanic African American,  non-Hispanic other
race, and Hispanic. Education attainment was grouped into 3 cat-
egories: less than a high school education, high school graduate, or
greater than a high school education. Age in years was grouped in-
to 3 categories: less than 50 years, 50 to 64 years, and 65 years or
older. Annual household income was grouped into 5 categories:
less than $15,000, $15,000 to less than $25,000, $25,000 to less
than $35,000, $35,000 to less than $50,000, and $50,000 or great-
er. Disability was based on a yes response to the question “Are
you limited in any activities because of physical, mental, or emo-
tional problems?” Health care coverage was assessed as a yes re-
sponse to the question “Do you have any kind of health care cov-
erage, including private health insurance, prepaid plans such as
HMOs [health maintenance organizations], or government plans
such as Medicare?”
Current smokers were defined as having smoked 100 cigarettes
during their lifetime and who currently smoke some days or every
day. Weight status was defined by body mass index (BMI), calcu-
lated as weight in kilograms divided by the square of height in
meters (kg/m2): underweight or normal (BMI <25 kg/m2), over-
weight (BMI 25–29.9 kg/m2), or obese (BMI ≥30 kg/m2). No leis-
ure-time physical activity was derived from a no response to the
question “During the past 30 days, other than your regular job, did
you participate in any physical activities or exercise such as run-
ning,  calisthenics,  golf,  gardening,  or  walking  for  exercise?”
Heavy drinking was defined as having more than 1 alcoholic drink
per day. The BRFSS cancer screening tests assessed were mam-
mography, clinical breast examination (CBE), Papanicolaou (Pap)
test, blood stool test, sigmoidoscopy or colonoscopy, and length of
time since most recent examinations. Comorbid conditions con-
sidered  for  potential  confounders  were  diabetes,  angina,  and
myocardial infarction.
As part of the BRFSS cancer survivorship optional module, re-
spondents were asked whether they had ever been told by a doctor,
nurse, or other health professional that they had cancer, and if yes,
the number of different cancers,  and age at diagnosis.  Women
with  a  diagnosis  of  a  single  type  of  cancer  were  selected  and
grouped into 4 categories by age at diagnosis: less than 40 years,
40 to 49 years, 50 to 79 years, and 80 years or older. Time since
diagnosis in years was calculated and also grouped into 4 categor-
ies: less than 5 years, 5 to 9 years, 10 to 19 years, and 20 or more
years. All cancer survivors were asked if they were currently re-
ceiving treatment. Women not currently in treatment were asked
what type of doctor provided most of their health care, whether
they had ever been given a written summary of cancer treatments
received or instructions for routine cancer check-ups, whether they
ever participated in a clinical trial as part of their treatment, wheth-
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er health insurance paid for all or part of treatment costs or if they
were ever denied insurance because of cancer, and current physic-
al pain related to the cancer or treatment and pain control status.
Statistical analysis
We calculated the proportion of women with risk factors for can-
cer and their engagement in preventive practices stratified by can-
cer status — breast cancer survivors, female survivors of other
cancers, and women without a history of cancer. Using multivari-
ate  logistic  regression,  we  compared  the  proportions  of  the  3
groups by adjusting for age, race, education, and household in-
come of participants. We also controlled for selected comorbid
conditions and general disability to assess the impact on the mod-
el. We further compared indicators of survivorship health status
for the 2 survivor groups and assessed the impact of time since
diagnosis on leisure-time physical inactivity and current physical
pain. Statistical significance was determined by 95% confidence
intervals (CIs) for the prevalence or adjusted odds ratios (AORs).
We used the χ2 test to compare the distributions of age at diagnos-
is and time since diagnosis between the breast cancer survivors
and other cancer survivors. The Missouri Department of Health
and Senior Services Institutional Review Board found this study to
be exempt from review. Data were analyzed by using SAS 9.4
(SAS Institute, Inc).
Results
Breast cancer survivors tended to be older (55.8% ≥ age 65) than
other cancer survivors (39.4%) and women with no history of can-
cer (17.2%) (Table 1). Most women in all 3 groups reported com-
pleting high school or had a higher than high school education. A
high proportion of women in each group had a household income
of $50,000 or more (39.7% for breast cancer survivors; 38.1% sur-
vivors of other cancer; 49.7% for women with no history of can-
cer), and the proportion was more than 10 percentage points high-
er for women with no history of cancer. Most of the women had
health insurance coverage. Among cancer survivors, the most fre-
quently  reported age at  diagnosis  was between age 50 and 79
(59.2% breast; 40.6% other cancer survivors); however, the fe-
male survivors of other types of cancer tended to be younger when
the cancer was diagnosed; 40.2% were given a diagnosis before
age 40. A small proportion of women survivors of other types of
cancer (1.2%) and even fewer breast cancer survivors (0.2%) re-
ported receiving their diagnosis before age 18. The time since dia-
gnosis differed significantly between the 2 cancer survivorship
groups. A larger proportion of female survivors of other cancer
types (21.6%) had 20 years or more since diagnosis compared
with breast cancer survivors (14.8%) (P < .001).
Survivorship health care
A  significantly  larger  proportion  of  breast  cancer  survivors
(16.5%; 95% CI, 13.3%–19.6%) than survivors of other cancers
(6.9%; 95% CI, 5.6%–8.3%) was currently receiving treatment. Of
the survivors not currently receiving treatment, primary care doc-
tors were reported as providing most health care for breast cancer
survivors (73.7%; 95% CI, 69.4%–78.0%) and other cancer sur-
vivors (72.8%; 95% CI, 70.4%–75.3%) (Table 2). Although ap-
proximately one-third of the cancer survivors received a written
summary of cancer treatments, a significantly greater proportion
of breast cancer survivors (39.3%; 95% CI, 34.7%–43.8%) than
other cancer survivors (27.8%; 95% CI, 25.2%–30.4%) received
such a summary. A significantly greater proportion of breast can-
cer survivors (80.0%; 95% CI, 76.2%–83.8%) than other cancer
survivors (67.9%; 95% CI, 65.3%–70.6%) received instructions on
routine cancer check-ups; fewer in either survivor group received
these instructions in a written or printed format (62.3%; 95% CI,
56.8%–67.9% breast cancer vs 63.7%; 95% CI, 60.0%–67.4% oth-
er cancer).
Health insurance paid for all or part of the cancer treatments of the
majority (>90%) of cancer survivors in both groups. A small pro-
portion of breast cancer survivors (8.1%; 95% CI, 5.9%–10.5%)
and other cancer survivors (7.6%; 95% CI, 6.0%–9.1%) had been
denied health insurance because of a cancer diagnosis. A small but
significantly greater proportion of breast cancer survivors had par-
ticipated in a clinical trial (8.1%; 95% CI, 5.8%–10.3%) com-
pared with other cancer survivors (4.2%; 95% CI, 2.9%–5.4%). A
significantly higher proportion of breast cancer survivors (15.1%;
95% CI, 11.4%–18.8%) than other cancer survivors (7.5%; 95%
CI, 6.0%–9.0%) reported current physical pain related to the can-
cer or its treatment; however, as length of time since diagnosis in-
creased, the proportions of survivors reporting pain significantly
declined for breast cancer survivors (P < .001) and female surviv-
ors of other cancer types (P < .001). A smaller proportion of breast
cancer survivors (8.8%; 95% CI, 1.9%–15.6%) than other cancer
survivors (20.3%; 95% CI, 12.0%–28.5%) reported their pain as
not under control.
Current smoking was significantly lower among breast cancer sur-
vivors (10.3%; 95% CI, 7.4%–13.2%) than among other female
cancer survivors (20.8%; 95% CI, 18.4%–23.3%) and women with
no history of cancer (18.3%; 95% CI, 17.5%–19.1%) (Table 3).
After adjusting for sociodemographic characteristics, we found
that other female cancer survivors were significantly more likely
than breast cancer survivors to be current smokers (AOR = 1.56;
95% CI, 1.04–2.32). The prevalence of overweight and obesity
was not significantly different among the 3 groups. However, in
the risk categories, a significantly higher proportion of breast can-
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cer survivors (34.1%; 95% CI, 30.1%–38.1%) did not engage in
leisure-time physical activity compared with women with no his-
tory of cancer (24.7%; 95% CI, 23.9%–25.5%), and this differ-
ence remained significant after we adjusted for sociodemographic
characteristics (AOR = 0.73; 95% CI, 0.59–0.90) (Table 3) and
persisted after we adjusted for disability (AOR = 0.77; 95% CI,
0.63–0.95). Similar to breast cancer survivors, one-third (32.7%);
AOR = 0.95; 95% CI, 0.72–1.17) of female survivors of other
types of cancer also reported no leisure time physical activity. Ad-
justing for time since diagnoses had little effect on the AOR for
physical activity (AOR = 0.91; 95% CI, 0.71–1.17) beyond the so-
cioeconomic  variables.  Heavy  drinking  was  low among  all  3
groups: 3.6% (95% CI, 2.3%–5.0%) for breast cancer survivors,
4.5% (95% CI, 3.4%–5.6%) for other cancer survivors, and 4.4%
(95% CI, 4.1%–4.8%) for women with no history of cancer. Dif-
ferences between groups were not significant.
Among women aged 40 or older, more than 90% in each group re-
ported  having  mammography  during  their  lifetime;  however,
breast cancer survivors had a significantly higher prevalence of
ever having mammography (99.8%; 95% CI, 99.5%–100.0%) than
other cancer survivors (95.7%; 95% CI, 94.5%–96.9%) and wo-
men without a history of cancer (91.3%; 95% CI,: 90.8%–91.9%)
(Table 3). The prevalence of mammography in the prior year was
significantly higher for breast cancer survivors (79.5%; 95% CI,
76.0%–83.0%) than for other cancer survivors (68.1%; 95% CI,
65.6%–70.7%) and women with no history of cancer (66.4%; 95%
CI, 65.5%–67.3%). In addition, breast cancer survivors had a sig-
nificantly higher prevalence of having a clinical breast examina-
tion within the previous year (84.2%; 95% CI, 81.0%–87.4%) than
other cancer survivors (70.5%; 95% CI, 67.9%–73.0%) and wo-
men with no history of cancer (68.6%; 95% CI, 67.8%–69.5%)
(Table 3). Furthermore, among women aged 21 to 65, breast can-
cer survivors were significantly more likely to have had a Pap test
within the preceding 3 years (89.4%; 95% CI, 85.9%–93.0%) than
women with no history of cancer (85.1%; 95% CI, 84.4%–85.8%).
Breast cancer survivors had a significantly higher prevalence of
ever having a lower endoscopy (ie,  sigmoidoscopy or  colono-
scopy; 79.9%; 95% CI, 76.6%–83.3%) than the women with no
history of cancer (65.1%; 95% CI, 64.2%–66.1%) and a higher
prevalence  of  having  had  a  colonoscopy  in  the  past  10  years
(75.4%; 95% CI, 71.7%–79.0%) than women with no history of
cancer (60.0%; 95% CI, 59.0%–61.0%).
In a subanalysis, the prevalence of never having a colonoscopy or
not having a colonoscopy in the previous 10 years was stratified
by sociodemographic characteristics. Breast cancer survivors with
a household income of less than $25,000 or without health insur-
ance  were  significantly  less  likely  to  be  in  compliance  with
colonoscopy screening guidelines (within the previous 10 years).
Discussion
This study found that breast cancer survivors were significantly
more likely to have had mammography, Pap tests, and colono-
scopy, and were less likely to be current smokers. The results of
this study align with the findings from previous breast cancer sur-
vivorship studies comparing female breast cancer patients and wo-
men with no history of cancer (18–20), and they expand the know-
ledge base with new information regarding risk factors, prevent-
ive practices, and survivorship health care among women with
other types of cancer.
The  American  Society  of  Clinical  Oncology  (ASCO)  recom-
mends that female breast cancer survivors treated with breast-con-
serving therapy have their first post-treatment mammogram 1 year
after the initial mammogram and no earlier than 6 months after
completion of radiation therapy. Thereafter, unless otherwise in-
dicated, a yearly mammographic evaluation should be performed
(21). In this study, among women aged 40 or older, breast cancer
survivors had a significantly higher prevalence of adherence to
guidelines of mammography screening in the previous year than
women in the other 2 groups. However, more than 20% of breast
cancer survivors did not have a mammogram in the previous year.
Regular gynecologic follow-up is recommended for all women ac-
cording to the ASCO breast cancer follow-up guidelines (21), and
the Healthy People 2020 goal is for 93% of women aged 21 to 65
to have had a Pap test within the past 3 years (22). In this study,
breast cancer survivors were significantly more likely to have had
a Pap test within the preceding 3 years (89.4%) than other cancer
survivors (84.2%) and women with no history of cancer (85.1%).
However, there is still room for improvement among all 3 groups
to achieve the Healthy People 2020 goal.
In this study, breast cancer survivors also had the highest preval-
ence of colonoscopy, and after we adjusted for sociodemographic
factors, their rate remained significantly higher than that of wo-
men without a history of cancer. In this study, 75.4% of female
breast  cancer  survivors  had a  colonoscopy in  the  previous  10
years, a rate that exceeds the Healthy People 2020 target of 70.5%
for colorectal cancer screening (22) and approaches the goal of
80%  by  2018  established  by  the  National  Colorectal  Cancer
Roundtable (23).
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The finding that female breast cancer survivors had a significantly
lower prevalence of smoking (10.3%) than other female cancer
survivors (20.8%) is consistent with the findings of Mayer et al
(20). Studies concur that cigarette smoking is associated with an
increased risk of squamous cell cancer of the cervix (24,25). May-
er  et  al  (20)  also  found a  high prevalence of  current  smoking
(48.9%) among women with cervical cancer.  The high current
smoking prevalence among women with other types of cancer in
this study may be attributable to the large proportion of women
with a history of cervical cancer in this group (15.4%).
Although research indicates that physical activity after a diagnosis
of breast cancer may be beneficial in improving quality of life and
reducing fatigue (26), a significantly higher proportion of female
breast cancer survivors did not engage in leisure-time physical
activity than the proportion of women with no history of cancer
but the difference was not significant from the proportion for wo-
men with other types of cancer. These findings seem to concur
with the finding that breast cancer survivors are more sedentary
than noncancer control women (27) and may benefit from inter-
ventions  promoting  greater  physical  activity.  Twice  as  many
breast cancer survivors (15.1%) as female survivors of other can-
cer types (7.5%) reported current physical pain, which may con-
tribute to the limited physical activity by both groups. The lower
percentage of pain among survivors of other cancer types can be
partly explained by the high proportion of skin cancer survivors
(excluding melanoma, 28.2%) in this group because non-melan-
oma skin cancer seldom spreads to other parts of the body and
treatment tends to be limited to the involved local site and not sys-
temic treatment as in most other cancer types.
Consistent with other studies, our study found that most breast
cancer survivors had health insurance (18,19) and that most of
their health care was provided by primary care providers (28,29).
This study showed that only about one-third of cancer survivors
not currently in treatment (39.3% of women with breast cancer
and 27.8% of women with other types of cancer) received a writ-
ten cancer treatment summary and about two-thirds (62.3% of
breast cancer survivors and 63.7% of women with other types of
cancer) received written instructions on routine cancer check-ups,
which is consistent with the findings of a previous study (30). In
addition, only a small proportion of each cancer survivor group
had participated in a clinical trial (8.1% of breast cancer survivors
and 4.2% of other cancer survivors).
The findings of this study have limitations. First, the BRFSS is
subject to self-report measurement bias, selection bias if a portion
of the population did not have landline telephone coverage, and
nonresponse bias if nonresponders differ significantly from re-
sponders. Cellular telephones were also not included in the 2010
BRFSS but have since been incorporated. Second, cervical cancer
may be overreported because of the similarities in treating cer-
vical  cancer  precursors  and  cervical  intraepithelial  neoplasia.
Third, diagnostic tests rather than screening tests may have been
reported by some respondents, possibly leading to overestimates
of screening. Fourth, the consumption of fruits and vegetables and
types and levels of physical activity were assessed through the
BRFSS every odd year, so these data were not available. Finally,
cancer survivors who may have advanced disease and be too ill to
participate in the survey or be residing in nursing homes, long-
term care facilities, or hospice are not included and therefore may
limit the generalizability of these results. Nevertheless, the BRFSS
provides the largest sample for estimates of risk factors available
because most cancer registries do not contain these data.
This study found that although a large proportion of breast cancer
survivors receive regular mammography, Pap tests, and colono-
scopy screening, there are significant opportunities for improve-
ment to meet the national health objectives. The study also found
that some breast cancer survivors continue to smoke, even though
the prevalence is lower than for women with other types of cancer
and women with no history of cancer.  Therefore,  the smoking
status of each patient must be assessed, and effective smoking ces-
sation interventions must be made available. These findings also
underscore the need for pain management for a portion of surviv-
ors and the need for more research to identify effective methods to
promote greater physical activity. Written treatment summaries
and follow-up instructions establish communication between the
cancer specialist, the primary care provider, and the patient to pro-
mote and enhance survivorship care coordination and self-man-
agement. These tailored-to-risk care plans should be developed for
each survivor to ensure that all of the survivors’ needs are met.
Findings of this study can be used by public health and health care
providers to improve cancer survivorship care and management.
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Tables
Table 1. Characteristics of Female Breast Cancer Survivors, Female Survivors of Other Cancer Types, and Women With No History
of Cancer, Behavioral Risk Factor Surveillance System, 9 US States and 1 US Territorya, 2010, (N = 39,235)
Characteristic
Breast Cancer Survivorsb





Overall 1,310 (100) 3,556 (100) 34,369 (100)
Race
Non-Hispanic white 1,122 (87.8) 3,091 (89.3) 26,726 (81.9)
Non-Hispanic African American 67 (5.5) 145 (4.0) 2,624 (7.3)
Non-Hispanic other 56 (3.4) 138 (3.9) 2,033 (4.7)
Hispanic 56 (3.3) 141 (2.7) 2,594 (6.0)
Age group, y
<50 94 (12.5) 605 (30.7) 13,114 (60.5)
50–64 388 (31.6) 1,096 (29.9) 10,575 (22.4)
≥65 810 (55.8) 1,826 (39.4) 10,267 (17.2)
Education
<High school 95 (5.6) 358 (9.3) 3,034 (7.0)
High school 415 (31.4) 1,170 (32.6) 10,453 (29.1)
>High school 798 (63.0) 2,015 (58.1) 20,800 (63.8)
Household income, $
<15,000 133 (9.7) 438 (12.4) 3,549 (8.4)
15,000–24,999 226 (17.5) 697 (21.4) 5,512 (15.9)
25,000–34,999 166 (16.3) 392 (13.8) 3,663 (12.0)
35,000–49,999 155 (16.7) 420 (14.2) 4,163 (13.9)
≥50,000 361 (39.7) 926 (38.1) 11,950 (49.7)
Age at cancer diagnosis, yf
<40 119 (12.7) 999 (40.2)  —  —
40–49 232 (21.5) 450 (13.3)  —  —
50–79 862 (59.2) 1,782 (40.6)  —  —
≥80 94 (6.6) 282 (5.8)  —  —
Time since cancer diagnosis, yf
Abbreviation: —, not applicable.
a The 9 states are Alaska, Connecticut, Indiana, Massachusetts, Missouri, New Mexico, Ohio, South Dakota, and Wisconsin, and the US territory is the Virgin Is-
lands.
b Women with 1 cancer only, excludes women with multiple types of cancer.
c Excludes breast cancer survivors.
d Denominator varies with missing and unknown excluded.
e May not sum to 100 because of rounding.
f Significant difference in the distribution of age at diagnosis and time since cancer diagnosis, χ2 testing (P < .001).
(continued on next page)
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(continued)
Table 1. Characteristics of Female Breast Cancer Survivors, Female Survivors of Other Cancer Types, and Women With No History
of Cancer, Behavioral Risk Factor Surveillance System, 9 US States and 1 US Territorya, 2010, (N = 39,235)
Characteristic
Breast Cancer Survivorsb





<5 418 (31.3) 1,222 (34.7)  —  —
5–9 299 (27.2) 655 (18.9)  —  —
10–19 375 (26.7) 827 (24.8)  —  —
≥20 218 (14.8) 851 (21.6)  —  —
Disability 450 (34.6) 1,320 (37.3) 8,615 (25.2)
No health insurance (aged 18–64 y) 30 (4.5) 159 (11.5) 2,812 (12.9)
Abbreviation: —, not applicable.
a The 9 states are Alaska, Connecticut, Indiana, Massachusetts, Missouri, New Mexico, Ohio, South Dakota, and Wisconsin, and the US territory is the Virgin Is-
lands.
b Women with 1 cancer only, excludes women with multiple types of cancer.
c Excludes breast cancer survivors.
d Denominator varies with missing and unknown excluded.
e May not sum to 100 because of rounding.
f Significant difference in the distribution of age at diagnosis and time since cancer diagnosis, χ2 testing (P < .001).
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Table 2. Comparison of Health Care Indicators for Breast Cancer Survivors and Female Survivors of Other Cancer Types, Behavior-
al Risk Factor Surveillance System, 9 US Statesa and 1 US Territory, 2010 (N = 4,866)
Health Care Indicator
Breast Cancer Survivorsb Female Survivors of Other Cancer
Typesb,c
Percentage (95% CI) [n]d Percentage (95% CI) [n]d
Overall n (%) 1,310 (100) 3,556 (100)
Currently receiving treatment (Surgery, radiation therapy, chemotherapy or
oral chemotherapy)
16.5 (13.3–19.6) [208] 6.9 (5.6–8.3) [264]
Doctor providing majority of health caree,f
Oncologist 10.1 (7.1–13.1) [105] 8.5 (7.1–10.1) [256]
Surgeon 5.6 (3.4–7.8) [68] 4.8 (3.6–6.0) [159]
Primary care 73.7 (69.4–78.0) [802] 72.8 (70.4–75.3) [2,314]
Other 10.6 (7.7–13.6) [94] 13.8 (11.9–15.6) [457]
Patient received written summary of cancer treatmentsf,g 39.3 (34.7–43.8) [401] 27.8 (25.2–30.4) [818]
Patient received instructions on routine cancer check-ups of where to return
or whom to seef,g
80.0 (76.2–83.8) [837] 67.9 (65.3–70.6) [2,073]
Patient received written or printed instructions on routine cancer check-upsf,g 62.3 (56.8–67.9) [485] 63.7 (60.0–67.4) [1,194]
Health insurance paid for all or part of cancer treatmentf 97.4 (96.0–98.8) [1,041] 92.9 (91.2–94.6) [2,965]
Ever denied health insurance because of cancer diagnosisf 8.1 (5.9–10.5) [102] 7.6 (6.0–9.1) [227]
Participated in clinical trialf 8.1 (5.8–10.3) [98] 4.2 (2.9–5.4) [110]
Current physical pain due to cancer or cancer treatmentf 15.1 (11.4–18.8) [128] 7.5 (6.0–9.0) [201]
Current physical pain by time since diagnosis, yf,h
<5 18.8 (11.3–26.3) [43] 11.6 (8.4–14.9) [93]
5–9 21.2 (13.0–29.5) [41] 6.6 (3.8–9.4) [48]
10–19 10.4 (5.3–15.5) [31] 7.3 (4.1–10.6) [38]
≥20 7.1 (1.3–13.0) [13] 2.6 (1.0–4.1) [22]
Pain not currently under controlf,i 8.8 (1.9–15.6) [14] 20.3 (12.0–28.5) [37]
a The 9 states are Alaska, Connecticut, Indiana, Massachusetts, Missouri, New Mexico, Ohio, South Dakota, and Wisconsin, and the US territory is the Virgin Is-
lands.
b Women with 1 cancer only, excludes women with multiple types of cancer.
c Excludes breast cancer survivors.
d Missing and unknown excluded.
e May not sum to 100 because of rounding.
f Excludes survivors undergoing treatment.
g Ever received from doctor, nurse, or other health professional.
h Significant decline breast cancer survivors (P < .001) and other survivors (P < .001).
i Among women with current physical pain due to cancer or cancer treatment.
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Table 3. Prevalence of Selected Risk Factors and Cancer Screenings Among 3 Groups of Women: Breast Cancer Survivorsa, Fe-
male Survivors of Other Cancer Typesa,b, and Women With No History of Cancer, Behavioral Risk Factor Surveillance System, 9 US
States and 1 Territoryc, 2010 (N = 39,235)
Risk Factors and Cancer Screening % (95% CI) [nd] Odds Ratio (95% CI) Adjusted ORe (95% CI)
Risk factors
Current smokerf
Breast cancer survivors 10.3 (7.4–13.2) [1,307] 1 [Reference]
Female survivors of other cancers 20.8 (18.4–23.3) [3,542] 2.28 (1.62–3.21) 1.56 (1.04–2.32)
Women with no history of cancer 18.3 (17.5–19.1) [34,201] 1.95 (1.43–2.66) 1.18 (0.81–1.71)
Overweight (BMI 25.0–29.9)
Breast cancer survivors 33.7 (29.6–37.8) [1,229] 1 [Reference]
Female survivors of other cancers 29.6 (27.1–32.0) [3,366] 0.83 (0.66–1.03) 0.95 (0.74–1.21)
Women with no history of cancer 29.1 (28.2–29.9) [31,989] 0.81 (0.67–0.97) 1.03 (0.83–1.28)
Obese (BMI ≥30.0)
Breast cancer survivors 26.6 (22.5–30.8) [1,229] 1 [Reference]
Female survivors of other cancers 29.1 (26.6–31.7) [3,366] 1.13 (0.89–1.45) 1.04 (0.79–1.38)
Women with no history of cancer 26.7 (25.8–27.5) [31,989] 1.00 (0.81–1.24) 0.93 (0.73–1.20)
No leisure-time physical activity in previous month
Breast cancer survivors 34.1 (30.1–38.1) [1,308] 1 [Reference]
Female survivors of other cancers 32.7 (30.2–35.3) [3,549] 0.94 (0.76–1.16) 0.95 (0.72–1.17)
Women with no history of cancer 24.7 (23.9–25.5) [34,332] 0.63 (0.53–0.76) 0.73 (0.59–0.90)
Heavy drinkingg
Breast cancer survivors 3.6 (2.3–5.0) [1,275] 1 [Reference]
Female survivors of other cancers 4.5 (3.4–5.6) [3,493] 1.25 (0.79–1.99) 1.24 (0.74–2.08)




Breast cancer survivors 99.8 (99.5–100.0) [1,281] 1 [Reference]
Female survivors of other cancers 95.7 (94.5–96.9) [3,331] 0.05 (0.02–0.19) 0.05.(0.01–0.26)
Abbreviation: CI, confidence interval.
a Women with 1 cancer only, excludes women with multiple types of cancer.
b Excludes breast cancer survivors.
c The 9 states are Alaska, Connecticut, Indiana, Massachusetts, Missouri, New Mexico, Ohio, South Dakota, and Wisconsin, and the US territory is the Virgin Is-
lands.
d Missing and unknown excluded.
e Adjusted for age, race, education and household income.
f Has smoked at least 100 cigarettes in lifetime and now smokes every day or some days.
g Consuming more than 1 drink per day.
h Women aged ≥40.
i Women aged 21 to 65.
j Women aged ≥50.
k Among those who ever had a sigmoidoscopy or colonoscopy.
(continued on next page)
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Table 3. Prevalence of Selected Risk Factors and Cancer Screenings Among 3 Groups of Women: Breast Cancer Survivorsa, Fe-
male Survivors of Other Cancer Typesa,b, and Women With No History of Cancer, Behavioral Risk Factor Surveillance System, 9 US
States and 1 Territoryc, 2010 (N = 39,235)
Risk Factors and Cancer Screening % (95% CI) [nd] Odds Ratio (95% CI) Adjusted ORe (95% CI)
Women with no history of cancer 91.3 (90.8–91.9) [27,495] 0.03 (0.01–0.09) 0.03 (0.01–0.14)
Last mammography < 1 year
Breast cancer survivors 79.5 (76.0–83.0) [1,266] 1 [Reference]
Female survivors of other cancers 68.1 (65.6–70.7) [3,193] 0.55 (0.43–0.70) 0.56 (0.43–0.74)
Women without a history of cancer 66.4 (65.5–67.3) [25,258] 0.51 (0.41–0.63) 0.51 (0.40–0.66)
Ever had clinical breast exam
Breast cancer survivors 98.1 (97.1–99.1) [1,277] 1 [Reference]
Female survivors of other cancers 93.2 (91.9–94.5) [3,314] 0.26 (0.15–0.47) 0.23 (0.11–0.49)
Women with no history of cancer 93.4 (93.0–93.9) [27,402] 0.28 (0.16–0.47) 0.20 (0.10–0.40)
Last clinical breast exam < 1 year
Breast cancer survivors 84.2 (81.0–87.4) [1,228] 1 [Reference]
Female survivors of other cancers 70.5 (67.9–73.0) [3,016] 0.45 (0.34–0.59) 0.45 (0.33–0.61)
Women with no history of cancer 68.6 (67.8–69.5) [24,910] 0.41 (0.32–.053) 0.36 (0.27–0.49)
Cervical cancer screeningi
Pap test < 3 years
Breast cancer survivors 89.4 (85.9–93.0) [517] 1 [Reference]
Female survivors of other cancers 84.2 (81.8–86.7) [1,771] 0.63 (0.42–0.96) 0.56 (0.35–0.90)
Women with no history of cancer 85.1 (84.4–85.8) [23,827] 0.67 (0.46–0.98) 0.47 (0.31–0.73)
Colorectal cancer screeningj
Ever had blood stool test
Breast cancer survivors 44.9 (40.6–49.2) [1,210] 1 [Reference]
Female survivors of other cancers 45.5 (42.7–48.3) [2,952] 0.78 (0.57–1.07) 1.12 (0.88–1.41)
Women with no history of cancer 38.2 (37.2–39.1) [21,482] 0.37 (0.28–0.49) 0.90 (0.73–1.10)
Last blood stool test <1 year
Breast cancer survivors 10.7 (8.2–13.2) [1,277] 1 [Reference]
Abbreviation: CI, confidence interval.
a Women with 1 cancer only, excludes women with multiple types of cancer.
b Excludes breast cancer survivors.
c The 9 states are Alaska, Connecticut, Indiana, Massachusetts, Missouri, New Mexico, Ohio, South Dakota, and Wisconsin, and the US territory is the Virgin Is-
lands.
d Missing and unknown excluded.
e Adjusted for age, race, education and household income.
f Has smoked at least 100 cigarettes in lifetime and now smokes every day or some days.
g Consuming more than 1 drink per day.
h Women aged ≥40.
i Women aged 21 to 65.
j Women aged ≥50.
k Among those who ever had a sigmoidoscopy or colonoscopy.
(continued on next page)
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Table 3. Prevalence of Selected Risk Factors and Cancer Screenings Among 3 Groups of Women: Breast Cancer Survivorsa, Fe-
male Survivors of Other Cancer Typesa,b, and Women With No History of Cancer, Behavioral Risk Factor Surveillance System, 9 US
States and 1 Territoryc, 2010 (N = 39,235)
Risk Factors and Cancer Screening % (95% CI) [nd] Odds Ratio (95% CI) Adjusted ORe (95% CI)
Female survivors of other cancers 8.5 (7.1–9.9) [3,502] 0.78 (0.57–1.07) 1.08 (0.75–1.56)
Women with no history of cancer 4.3 (4.0–4.5) [34,044] 0.37 (0.28–0.49) 0.98 (0.72–1.34)
Ever had sigmoidoscopy/colonoscopy
Breast cancer survivors 79.9 (76.6–83.3) [1,213] 1 [Reference]
Female survivors of other cancers 76.7 (74.2–79.1) [2,971] 0.83 (0.64–1.06) 0.84 (0.63–1.11)
Women with no history of cancer 65.1 (64.2–66.1) [21,520] 0.47 (0.38–0.58) 0.48 (0.38–0.62)
Most recent sigmoidoscopyk
Breast cancer survivors 3.5 (2.2–4.8) [1,188] 1 [Reference]
Female survivors of other cancers 4.5 (3.1–5.9) [2,911] 1.29 (0.79–2.13) 1.14 (0.69–1.88)
Women with no history of cancer 3.7 (3.3–4.1) [21,187] 1.06 (0.72–1.56) 1.17 (0.76–1.79)
Last sigmoidoscopy exam <5 yearsk
Breast cancer survivors 1.9 (1.0–2.8) [1,164] 1 [Reference]
Female survivors of other cancers 2.3 (1.6–3.1) [2,852] 1.21 (0.68–2.17) 1.14 (0.60–2.16)
Women with no history of cancer 2.1 (1.8–2.4) [20,813] 1.08 (0.66–1.78) 1.06 (0.61–1.82)
Most recent colonoscopyk
Breast cancer survivors 76.1 (72.6–79.7) [1,188] 1 [Reference]
Female survivors of other cancers 71.7 (69.1–74.4) [2,911] 0.80 (0.63–1.01) 0.85 (0.65–1.10)
Women with no history of cancer 61.0 (60.0–62.0) [21,187] 0.49 (0.40–0.60) 0.51 (0.41–0.63)
Last colonoscopy exam <10 years agok
Breast cancer survivors 75.4 (71.7–79.0) [1,154] 1 [Reference]
Female survivors of other cancers 70.8 (68.0–73.5) [2,821] 0.80 (0.64–0.99) 0.85 (0.65–1.11)
Women with no history of cancer 60.0 (59.0–61.0) [20,643] 0.53 (0.44–0.64) 0.51 (0.41–0.64)
Abbreviation: CI, confidence interval.
a Women with 1 cancer only, excludes women with multiple types of cancer.
b Excludes breast cancer survivors.
c The 9 states are Alaska, Connecticut, Indiana, Massachusetts, Missouri, New Mexico, Ohio, South Dakota, and Wisconsin, and the US territory is the Virgin Is-
lands.
d Missing and unknown excluded.
e Adjusted for age, race, education and household income.
f Has smoked at least 100 cigarettes in lifetime and now smokes every day or some days.
g Consuming more than 1 drink per day.
h Women aged ≥40.
i Women aged 21 to 65.
j Women aged ≥50.
k Among those who ever had a sigmoidoscopy or colonoscopy.
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